205 related articles for article (PubMed ID: 11281024)
1. The application of a compact multispectral imaging system with integrated excitation source to in vivo monitoring of fluorescence during topical photodynamic therapy of superficial skin cancers.
Hewett J; Nadeau V; Ferguson J; Moseley H; Ibbotson S; Allen JW; Sibbett W; Padgett M
Photochem Photobiol; 2001 Mar; 73(3):278-82. PubMed ID: 11281024
[TBL] [Abstract][Full Text] [Related]
2. [Topical photodynamic therapy in basal and squamous cell carcinoma and penile Bowen's disease with 20% aminolevulinic acid, and exposure to red light and infrared light].
Harth Y; Hirshovitz B
Harefuah; 1998 Apr; 134(8):602-5, 672, 671. PubMed ID: 10911421
[TBL] [Abstract][Full Text] [Related]
3. Aminolevulinic acid photodynamic therapy for skin cancers.
Blume JE; Oseroff AR
Dermatol Clin; 2007 Jan; 25(1):5-14. PubMed ID: 17126737
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma.
Dijkstra AT; Majoie IM; van Dongen JW; van Weelden H; van Vloten WA
J Eur Acad Dermatol Venereol; 2001 Nov; 15(6):550-4. PubMed ID: 11843215
[TBL] [Abstract][Full Text] [Related]
5. Red light laser photodynamic therapy of Bowen's disease.
Parlette EC
J Drugs Dermatol; 2004; 3(6 Suppl):S22-4. PubMed ID: 15624738
[No Abstract] [Full Text] [Related]
6. Efficacy of photodynamic therapy with topical 5-aminolevulinic acid using intense pulsed light for Bowen's disease.
Hasegawa T; Suga Y; Mizuno Y; Haruna K; Ogawa H; Ikeda S
J Dermatol; 2010 Jul; 37(7):623-8. PubMed ID: 20629828
[TBL] [Abstract][Full Text] [Related]
7. An open pilot study of ambulatory photodynamic therapy using a wearable low-irradiance organic light-emitting diode light source in the treatment of nonmelanoma skin cancer.
Attili SK; Lesar A; McNeill A; Camacho-Lopez M; Moseley H; Ibbotson S; Samuel ID; Ferguson J
Br J Dermatol; 2009 Jul; 161(1):170-3. PubMed ID: 19302071
[TBL] [Abstract][Full Text] [Related]
8. [The wider application of photodynamic therapy in dermatology].
Thissen MR; Kuijpers DI; Neumann HA
Ned Tijdschr Geneeskd; 2005 Jan; 149(5):232-7. PubMed ID: 15719833
[TBL] [Abstract][Full Text] [Related]
9. Topical 5-aminolevulinic acid and photodynamic therapy in dermatology: a minireview.
Cappugi P; Campolmi P; Mavilia L; Prignano F; Rossi R
J Chemother; 2001 Oct; 13(5):494-502. PubMed ID: 11760213
[TBL] [Abstract][Full Text] [Related]
10. Topical photodynamic therapy for Bowen's disease of the digit in epidermolysis bullosa.
Souza CS; Felício LB; Bentley MV; Tedesco AC; Ferreira J; Kurachi C; Bagnato VS
Br J Dermatol; 2005 Sep; 153(3):672-4. PubMed ID: 16120168
[No Abstract] [Full Text] [Related]
11. Subungual Bowen's disease treated by topical aminolevulinic acid-photodynamic therapy.
Usmani N; Stables GI; Telfer NR; Stringer MR
J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S273-6. PubMed ID: 16227107
[TBL] [Abstract][Full Text] [Related]
12. Large patches of Bowen's disease treated by topical aminolaevulinic acid photodynamic therapy.
Stables GI; Stringer MR; Robinson DJ; Ash DV
Br J Dermatol; 1997 Jun; 136(6):957-60. PubMed ID: 9217836
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy for non-melanoma skin cancer.
Szeimies RM; Morton CA; Sidoroff A; Braathen LR
Acta Derm Venereol; 2005; 85(6):483-90. PubMed ID: 16396794
[TBL] [Abstract][Full Text] [Related]
14. Superficial blood flow following photodynamic therapy of malignant non-melanoma skin tumours measured by laser Doppler perfusion imaging.
Wang I; Andersson-Engels S; Nilsson GE; Wårdell K; Svanberg K
Br J Dermatol; 1997 Feb; 136(2):184-9. PubMed ID: 9068729
[TBL] [Abstract][Full Text] [Related]
15. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients.
Dragieva G; Hafner J; Dummer R; Schmid-Grendelmeier P; Roos M; Prinz BM; Burg G; Binswanger U; Kempf W
Transplantation; 2004 Jan; 77(1):115-21. PubMed ID: 14724445
[TBL] [Abstract][Full Text] [Related]
16. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
[TBL] [Abstract][Full Text] [Related]
17. Topical photodynamic therapy for primary Bowen disease and basal cell carcinoma: optimizing patient selection.
Hambly R; Mansoor N; Quinlan C; Shah Z; Lenane P; Ralph N; Moloney FJ
Br J Dermatol; 2017 Sep; 177(3):e55-e57. PubMed ID: 28028807
[No Abstract] [Full Text] [Related]
18. Recurrence rate of basal cell carcinoma after topical aminolevulinic acid-based photodynamic therapy.
Naidenov N; Dencheva R; Tsankov N
Acta Dermatovenerol Croat; 2004; 12(3):157-61. PubMed ID: 15369639
[TBL] [Abstract][Full Text] [Related]
19. Fractionated illumination improves the outcome in the treatment of precancerous lesions with photodynamic therapy.
Puizina-Ivić N; Zorc H; Vanjaka-Rogosić L; Mirić L; Persin A
Coll Antropol; 2008 Oct; 32 Suppl 2():67-73. PubMed ID: 19138010
[TBL] [Abstract][Full Text] [Related]
20. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome.
Itkin A; Gilchrest BA
Dermatol Surg; 2004 Jul; 30(7):1054-61. PubMed ID: 15209801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
